The researchers from National University of Singapore analysed the results of 82 observational studies comparing the effectiveness of COVID...

Researchers at Yale School of Medicine in the US noted that the molecule could lead to new treatments for COVID-19 in immunocompromised pat...

The Tocilizumab drug may be considered for use in the presence of severe disease (preferably within 24 to 48 hours of onset of severe disea...

Answering a list of frequently asked questions (FAQs) about the Omicron variant of coronavirus, the Health Ministry has said that while the...

A booster dose is given to an individual after a predefined period when the immune response due to primary vaccination is presumed to have ...

Experts are of the view that in diseases like cancer, the body of patients undergoing chemotherapy may not be able to generate enough immun...

The treatment was used as part of the suite of experimental medicines given to Trump when he tested positive for COVID-19 last year.

Booster shots are often identical to the original vaccine.

Immunocompromised people aren't a uniform group, and so may respond to vaccines differently.

Several studies have indicated that a third coronavirus vaccine dose might succeed in patients who did not have detectable antibodies after...

7.9 lakh vials have been allocated across the country, maintaining adequate availability to patients of mucormycosis. Amphotericin-B is use...

Amphotericin-B is used to treat mucormycosis, also known as black fungus infection.

As per the Union Health Ministry, Mucormycosis is being detected among patients who are recovering or have recovered from COVID-19.

The fungal infection is caused by a group of molds called mucormycetes. These molds live throughout the environment. Mucormycosis mainly af...

This could mean a large section of the people with comorbidities such as diabetes, hypertension and heart disease — who are among the prior...

Scientists have assessed respiratory samples from 35 COVID-19 patients, and found that contagious coronavirus was "rarely detectable" beyon...

The company has received approval from the USFDA for its abbreviated new drug application (ANDA) Acyclovir ointment USP, 5 per cent, Alembi...